Alexander Hein

机构：Klinikum Esslingen · ORCID：0000-0003-2601-3398

发表论文 416 篇 · 总被引 16799 次 · h-index 53

代表论文

Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers (2025 · Breast Cancer Research · 被引 9)
Characteristics and prognosis of patients with primary metastatic disease vs. recurrent HER2-negative, hormone receptor-positive advanced breast cancer (2025 · The Breast · 被引 7)
Real-world utilization of aromatase inhibitors, tamoxifen, and ovarian function suppression in premenopausal patients with early hormone receptor-positive, HER2-negative breast cancer with increased recurrence risk (2025 · The Breast · 被引 5)
PARP inhibition with olaparib and talazoparib for HER2-negative advanced breast cancer—Results from the prospective PRAEGNANT registry (2026 · npj Breast Cancer · 被引 2)
Alpelisib and Fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the German PRAEGNANT trial (2026 · Breast Cancer Research and Treatment · 被引 1)
Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer (2025 · European Journal of Cancer · 被引 1)